1-2 of 2
Brenda Martone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In vivo Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna

Gerald A. Soff, Hao Wang, Deborah L. Cundiff, Keyi Jiang, Brenda Martone, Alfred W. Rademaker, Jennifer A. Doll, Timothy M. Kuzel
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6218–6225.
https://doi.org/10.1158/1078-0432.CCR-04-1514
Published: 06 September 2005
View article titled, <em>In vivo</em> Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna
Open the PDF for <em>In vivo</em> Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna in another window
Journal Articles

Daily Subcutaneous Ultra-Low-Dose Interleukin 2 with Daily Low-Dose Interferon-α in Patients with Advanced Renal Cell Carcinoma

Joseph I. Clark, Ellen R. Gaynor, Brenda Martone, Susan C. Budds, Rajini Manjunath, Robert C. Flanigan, W. Bedford Waters, Jeffrey A. Sosman
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2374–2380.
Published: 01 September 1999
View article titled, Daily Subcutaneous Ultra-Low-Dose Interleukin 2 with Daily Low-Dose Interferon-α in Patients with Advanced Renal Cell Carcinoma
Open the PDF for Daily Subcutaneous Ultra-Low-Dose Interleukin 2 with Daily Low-Dose Interferon-α in Patients with Advanced Renal Cell Carcinoma in another window